Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention

Published:2023-10 Issue:20 Volume:16 Page:2528-2539
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Franchi Francesco^ORCID,Rollini Fabiana,Ortega-Paz Luis^ORCID,Been Latonya,Giordano Salvatore^ORCID,Galli Mattia^ORCID,Ghanem Ghussan,Garabedian Haroutioun,Al Saleh Tala,Uzunoglu Ekin^ORCID,Rivas Andrea,Pineda Andres M.,Suryadevara Siva,Soffer Daniel,Zenni Martin M.,Mahowald Madeline,Reiter Birgit,Jilma Bernd,Angiolillo Dominick J.

Funder

Scott R MacKenzie Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Cangrelor: a review on pharmacology and clinical trial development;Franchi;Expert Rev Cardiovasc Ther,2013

2. Switching P2Y12-receptor inhibitors in patients with coronary artery disease;Rollini;Nat Rev Cardiol,2016

3. International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies;Angiolillo;Circulation,2017

4. Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect;Steinhubl;Thromb Res,2008

5. The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function;Dovlatova;J Thromb Haemost,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immediate Platelet Inhibition Strategy for Comatose Out-of-Hospital Cardiac Arrest Survivors Undergoing Percutaneous Coronary Intervention and Mild Therapeutic Hypothermia;Journal of Clinical Medicine;2024-04-06

2. P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study;JACC: Cardiovascular Interventions;2024-04

3. North American perspective on the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2023-12-13

4. Effective and Safe Transition Between Intravenous and Oral P2Y12 Antagonists;JACC: Cardiovascular Interventions;2023-10